Neurotech International

Established in WA: 2016
Level 14, 191 St Georges Terrace, PERTH, 6000
(08) 9321 5922
Neurotech International is a medical device and solutions company incorporated in Australia, operating through its wholly-owned, Malta-based subsidiary, AAT Research Limited. Neurotech provides medical solutions for the management of neurological disorders including autism spectrum disorder (ASD), epilepsy, anxiety and depression. The company’s core product is Mente Autism, a device that uses neurofeedback technology to help children with ASD.
Bio last updated 04 Nov 2016

Article Timeline

Access to our data for Neurotech International is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Neurotech International is included in 1 list - Public Companies - Industrial.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

To access ,

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
69thBotanix Pharmaceuticals164%106%
144thUltima United90%5%
679thNeurotech International-36%0%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$113k Issued
$66k Issued
Total value as at the date of the transaction
Source: Morningstar


184th↑Neurotech International$104k
207th↓Ultima United$2k
210th↓Mission NewEnergy$5
211th↓Botanix Pharmaceuticals$0
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer